TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today announced that the prognostic value of its Microvolt T-Wave Alternans™ (MTWA) test was recently featured in Diagnostic and Interventional Cardiology (DAIC) as the Case of the Week.
